MP
ACRS icon

MFN Partners’s Aclaris Therapeutics ACRS Stock Holding History

MFN Partners’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,338,718
Closed -$5.41M – 17
2020
Q2 		$5.41M Sell
3,338,718
-661,282
-17% -$886K 0.75% 11
2020
Q1 		$4.16M Hold
4,000,000
– – 0.55% 15
2019
Q4 		$7.56M Buy
4,000,000
+2,500,000
+167% +$4.14M 1.56% 9
2019
Q3 		$1.62M Hold
1,500,000
– – 0.24% 13
2019
Q2 		$3.29M Hold
1,500,000
– – 0.52% 15
2019
Q1 		$8.98M Hold
1,500,000
– – 1.57% 13
2018
Q4 		$11.1M Buy
+1,500,000
New +$15.5M 1.88% 12

Other funds holding ACRS

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $965M AUM 79.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return